Clinical Trials Logo

Posology Adjustment clinical trials

View clinical trials related to Posology Adjustment.

Filter by:
  • None
  • Page 1

NCT ID: NCT04733079 Recruiting - Gout Clinical Trials

Treat-to-target by Email During Urate-lowering Therapy in Gout

GOUTEmail
Start date: December 15, 2021
Phase: N/A
Study type: Interventional

Gout is secondary to urate crystal deposition after chronic elevation of serum urate level (SUL). Long-term lowering SUL below 360 µmol/L allows dissolution of deposited crystals and disease cure. There is currently a paradoxical observation: while urate-lowering therapy (ULT) is available and efficient there is an increase of gout prevalence and severity. The apparent failure of ULT in gout management is due to several causes including unadjusted dosage, no SUL verification, irregular follow-up and low treatment compliance. In contrast, a nurse-led treat-to-target (T2T) strategy with regular adaptations of ULT until reaching SUL target allows gout cure in more than 90% of patients. We hypothesize that an electronic messaging-led T2T strategy will allow obtaining similar results. The aim of this study is to demonstrate that email-led T2T strategy during ULT is superior to usual care.